http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 04 May 2026 16:37:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+May+01++Filed+by%3A+Tattoli+Mark+Damian/26426559.html si-local-file:///var/storage/secattach/20260504/26426559.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+May+01++Filed+by%3A+Tattoli+Mark+Damian/26426559.html Mon, 04 May 2026 16:37:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+May+01++Filed+by%3A+Tattoli+Mark+Damian/26426559.html si-local-file:///var/storage/secattach/20260504/26426559.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+May+01++Filed+by%3A+Tattoli+Mark+Damian/26426559.html Mon, 04 May 2026 16:37:00 -0400 CLB O.00555479 http://www.streetinsider.com/Earnings/Core+Laboratories+%28CLB%29+Misses+Q1+EPS+by+20c/26398135.html <p>Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.06, $0.20 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $121.8 million versus the consensus estimate of $0 .</p><p>For earnings history and earnings-related data on Core Laboratories (CLB) <a href="http://www.streetinsider.com/ec_earnings.php?q=CLB">click here</a>.</p> http://www.streetinsider.com/Earnings/Core+Laboratories+%28CLB%29+Misses+Q1+EPS+by+20c/26398135.html Thu, 30 Apr 2026 02:13:49 -0400 CLB http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF <money>$121.8</money></b><b> MILLION, DOWN 12%</b><b> SEQUENTIALLY AND FLAT YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF <money>$1.9 MILLION</money>; EX-ITEMS, <money>$6.6 MILLION</money>, DOWN 58% SEQUENTIALLY AND <br />44% YEAR-OVER-YEAR</b></li><li><b>GAAP LOSS PER SHARE OF</b><b> <money>$0.02</money></b><b>; EPS EX-ITEMS OF <money>$0.06</money>, DOWN 72% SEQUENTIALLY AND <br />58% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF <money>$0.5 MILLION</money></b></li><li><b>NET DEBT INCREASED BY <money>$3.9 MILLION</money>; LEVERAGE RATIO AT 1.20</b></li><li><b>COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR <money>$0.9 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>April 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported first quarter 2026 revenue of http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html Wed, 29 Apr 2026 17:15:00 -0400 CLB CLB O.00555479 http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF <money>$121.8</money></b><b> MILLION, DOWN 12%</b><b> SEQUENTIALLY AND FLAT YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF <money>$1.9 MILLION</money>; EX-ITEMS, <money>$6.6 MILLION</money>, DOWN 58% SEQUENTIALLY AND <br />44% YEAR-OVER-YEAR</b></li><li><b>GAAP LOSS PER SHARE OF</b><b> <money>$0.02</money></b><b>; EPS EX-ITEMS OF <money>$0.06</money>, DOWN 72% SEQUENTIALLY AND <br />58% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF <money>$0.5 MILLION</money></b></li><li><b>NET DEBT INCREASED BY <money>$3.9 MILLION</money>; LEVERAGE RATIO AT 1.20</b></li><li><b>COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR <money>$0.9 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>April 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported first quarter 2026 revenue of http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html Wed, 29 Apr 2026 17:15:00 -0400 CLB CLB O.00555479 http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF <money>$121.8</money></b><b> MILLION, DOWN 12%</b><b> SEQUENTIALLY AND FLAT YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF <money>$1.9 MILLION</money>; EX-ITEMS, <money>$6.6 MILLION</money>, DOWN 58% SEQUENTIALLY AND <br />44% YEAR-OVER-YEAR</b></li><li><b>GAAP LOSS PER SHARE OF</b><b> <money>$0.02</money></b><b>; EPS EX-ITEMS OF <money>$0.06</money>, DOWN 72% SEQUENTIALLY AND <br />58% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF <money>$0.5 MILLION</money></b></li><li><b>NET DEBT INCREASED BY <money>$3.9 MILLION</money>; LEVERAGE RATIO AT 1.20</b></li><li><b>COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR <money>$0.9 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>April 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported first quarter 2026 revenue of http://www.streetinsider.com/Press+Releases/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html Wed, 29 Apr 2026 17:15:00 -0400 CLB CLB O.00555479 http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF <money>$121.8</money></b><b> MILLION, DOWN 12%</b><b> SEQUENTIALLY AND FLAT YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF <money>$1.9 MILLION</money>; EX-ITEMS, <money>$6.6 MILLION</money>, DOWN 58% SEQUENTIALLY AND <br />44% YEAR-OVER-YEAR</b></li><li><b>GAAP LOSS PER SHARE OF</b><b> <money>$0.02</money></b><b>; EPS EX-ITEMS OF <money>$0.06</money>, DOWN 72% SEQUENTIALLY AND <br />58% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF <money>$0.5 MILLION</money></b></li><li><b>NET DEBT INCREASED BY <money>$3.9 MILLION</money>; LEVERAGE RATIO AT 1.20</b></li><li><b>COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR <money>$0.9 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>April 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported first quarter 2026 revenue of http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html Wed, 29 Apr 2026 17:15:00 -0400 CLB CLB O.00555479 http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF <money>$121.8</money></b><b> MILLION, DOWN 12%</b><b> SEQUENTIALLY AND FLAT YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF <money>$1.9 MILLION</money>; EX-ITEMS, <money>$6.6 MILLION</money>, DOWN 58% SEQUENTIALLY AND <br />44% YEAR-OVER-YEAR</b></li><li><b>GAAP LOSS PER SHARE OF</b><b> <money>$0.02</money></b><b>; EPS EX-ITEMS OF <money>$0.06</money>, DOWN 72% SEQUENTIALLY AND <br />58% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF <money>$0.5 MILLION</money></b></li><li><b>NET DEBT INCREASED BY <money>$3.9 MILLION</money>; LEVERAGE RATIO AT 1.20</b></li><li><b>COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR <money>$0.9 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>April 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported first quarter 2026 revenue of http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html Wed, 29 Apr 2026 17:15:00 -0400 CLB CLB O.00555479 http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html <div class="xn-content"> <ul type="disc"><li><b>REVENUE OF <money>$121.8</money></b><b> MILLION, DOWN 12%</b><b> SEQUENTIALLY AND FLAT YEAR-OVER-YEAR</b></li><li><b>OPERATING INCOME OF <money>$1.9 MILLION</money>; EX-ITEMS, <money>$6.6 MILLION</money>, DOWN 58% SEQUENTIALLY AND <br />44% YEAR-OVER-YEAR</b></li><li><b>GAAP LOSS PER SHARE OF</b><b> <money>$0.02</money></b><b>; EPS EX-ITEMS OF <money>$0.06</money>, DOWN 72% SEQUENTIALLY AND <br />58% YEAR-OVER-YEAR</b></li><li><b>FREE CASH FLOW OF <money>$0.5 MILLION</money></b></li><li><b>NET DEBT INCREASED BY <money>$3.9 MILLION</money>; LEVERAGE RATIO AT 1.20</b></li><li><b>COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR <money>$0.9 MILLION</money> AGGREGATE PURCHASE PRICE</b></li><li><b>COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>April 29, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") reported first quarter 2026 revenue of http://www.streetinsider.com/PRNewswire/CORE+LAB+REPORTS+FIRST+QUARTER+2026+RESULTS/26396908.html Wed, 29 Apr 2026 17:15:00 -0400 CLB CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Murray+Katherine/26288225.html si-local-file:///var/storage/secattach/20260408/26288225.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Murray+Katherine/26288225.html Wed, 08 Apr 2026 12:22:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Murray+Katherine/26288225.html si-local-file:///var/storage/secattach/20260408/26288225.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Murray+Katherine/26288225.html Wed, 08 Apr 2026 12:22:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+ANASTASIO+CURT/26284606.html si-local-file:///var/storage/secattach/20260407/26284606.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+ANASTASIO+CURT/26284606.html Tue, 07 Apr 2026 19:48:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+ANASTASIO+CURT/26284606.html si-local-file:///var/storage/secattach/20260407/26284606.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+ANASTASIO+CURT/26284606.html Tue, 07 Apr 2026 19:48:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Klingensmith+Harvey+Robert/26284603.html si-local-file:///var/storage/secattach/20260407/26284603.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Klingensmith+Harvey+Robert/26284603.html Tue, 07 Apr 2026 19:47:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Klingensmith+Harvey+Robert/26284603.html si-local-file:///var/storage/secattach/20260407/26284603.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Klingensmith+Harvey+Robert/26284603.html Tue, 07 Apr 2026 19:47:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Temeng+Kwaku/26284602.html si-local-file:///var/storage/secattach/20260407/26284602.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Temeng+Kwaku/26284602.html Tue, 07 Apr 2026 19:45:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Temeng+Kwaku/26284602.html si-local-file:///var/storage/secattach/20260407/26284602.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Temeng+Kwaku/26284602.html Tue, 07 Apr 2026 19:45:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+MARTINOVICH+ROBERT+F/26284598.html si-local-file:///var/storage/secattach/20260407/26284598.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+MARTINOVICH+ROBERT+F/26284598.html Tue, 07 Apr 2026 19:43:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+MARTINOVICH+ROBERT+F/26284598.html si-local-file:///var/storage/secattach/20260407/26284598.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+MARTINOVICH+ROBERT+F/26284598.html Tue, 07 Apr 2026 19:43:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Carnes+Martha+Z./26284592.html si-local-file:///var/storage/secattach/20260407/26284592.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Carnes+Martha+Z./26284592.html Tue, 07 Apr 2026 19:42:00 -0400 CLB O.00555479 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Carnes+Martha+Z./26284592.html si-local-file:///var/storage/secattach/20260407/26284592.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Core+Laboratories+Inc.++++For%3A+Apr+01++Filed+by%3A+Carnes+Martha+Z./26284592.html Tue, 07 Apr 2026 19:42:00 -0400 CLB O.00555479 http://www.streetinsider.com/Guidance/Core+Lab+cuts+Q1+2026+guidance+due+to+Middle+East+conflict/26204483.html <p>Core Laboratories Inc. (NYSE: CLB) revised its first quarter 2026 financial guidance downward due to ongoing geopolitical conflict in the Middle East affecting its operations and client activities.</p><p>The Houston-based oil services company now projects first quarter revenue between $119 million and $123 million, with operating income expected to range from $5.7 million to $7.1 million. Earnings per share are forecast at $0.05 to $0.07 for the quarter.</p><p>Regional instability has created client-driven project delays, travel constraints, and supply-chain disruptions that are impacting the company's operations across Middle Eastern countries where it maintains a presence. Damage to oil refining infrastructure and storage http://www.streetinsider.com/Guidance/Core+Lab+cuts+Q1+2026+guidance+due+to+Middle+East+conflict/26204483.html Mon, 23 Mar 2026 17:00:41 -0400 CLB http://www.streetinsider.com/Corporate+News/Core+Lab+cuts+Q1+2026+guidance+due+to+Middle+East+conflict/26204483.html <p>Core Laboratories Inc. (NYSE: CLB) revised its first quarter 2026 financial guidance downward due to ongoing geopolitical conflict in the Middle East affecting its operations and client activities.</p><p>The Houston-based oil services company now projects first quarter revenue between $119 million and $123 million, with operating income expected to range from $5.7 million to $7.1 million. Earnings per share are forecast at $0.05 to $0.07 for the quarter.</p><p>Regional instability has created client-driven project delays, travel constraints, and supply-chain disruptions that are impacting the company's operations across Middle Eastern countries where it maintains a presence. Damage to oil refining infrastructure and storage http://www.streetinsider.com/Corporate+News/Core+Lab+cuts+Q1+2026+guidance+due+to+Middle+East+conflict/26204483.html Mon, 23 Mar 2026 17:00:41 -0400 CLB http://www.streetinsider.com/Hot+Corp.+News/Core+Lab+cuts+Q1+2026+guidance+due+to+Middle+East+conflict/26204483.html <p>Core Laboratories Inc. (NYSE: CLB) revised its first quarter 2026 financial guidance downward due to ongoing geopolitical conflict in the Middle East affecting its operations and client activities.</p><p>The Houston-based oil services company now projects first quarter revenue between $119 million and $123 million, with operating income expected to range from $5.7 million to $7.1 million. Earnings per share are forecast at $0.05 to $0.07 for the quarter.</p><p>Regional instability has created client-driven project delays, travel constraints, and supply-chain disruptions that are impacting the company's operations across Middle Eastern countries where it maintains a presence. Damage to oil refining infrastructure and storage http://www.streetinsider.com/Hot+Corp.+News/Core+Lab+cuts+Q1+2026+guidance+due+to+Middle+East+conflict/26204483.html Mon, 23 Mar 2026 17:00:41 -0400 CLB http://www.streetinsider.com/Press+Releases/CORE+LAB+ANNOUNCES+IMPACT+OF+THE+MIDDLE+EAST+CONFLICT+TO+FIRST+QUARTER+2026+GUIDANCE/26204475.html <div class="xn-content"> <p class="prntac"><b>FIRST QUARTER 2026 EARNINGS WEBCAST AT <chron>7:30 A.M. CDT</chron> / <chron>8:30 A.M. EDT</chron> ON <chron>APRIL 30, 2026</chron></b></p><p><span class="legendSpanClass"><location value="LU/us.tx.houstn" idsrc="xmltag.org" >HOUSTON</location></span>, <span class="legendSpanClass"><chron>March 23, 2026</chron></span> /PRNewswire/ -- <span>Core Laboratories Inc.</span> (NYSE: "CLB") ("Core," "<span>Core Lab</span>," or the "Company") continues to evaluate and monitor the evolving geopolitical conflict in the <location value="LR/mde" idsrc="xmltag.org" >Middle East</location> and its effect on the Company's first quarter 2026 financial results. <span>Core Lab</span> is working with clients and its local teams to manage operations and mitigate impacts on project execution through a rapidly changing operating environment. The safety and security of the Company's employees http://www.streetinsider.com/Press+Releases/CORE+LAB+ANNOUNCES+IMPACT+OF+THE+MIDDLE+EAST+CONFLICT+TO+FIRST+QUARTER+2026+GUIDANCE/26204475.html Mon, 23 Mar 2026 17:00:00 -0400 A.09642568 CLB O.00555479 O.20371933